temsirolimus
Vorinostat (SAHA) | HDAC Inhibitor | Read.
Renal cell carcinoma - bevacizumab, sorafenib, sunitinib and temsirolimus: appraisal consultation document
Vorinostat (suberoylanilide hydroxamic acid, SAHA, Zolinza) is a HDAC…Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations
Temsirolimus (CCI-779, Torisel) is a specific mTOR inhibitor with IC5…Quality confirmed by NMR & HPLC. See customer reviews, validations & product citations
Find information on advanced renal cell carcinoma, a type of kidney cancer. Read about treatment options and potential risks for TORISEL® (temsirolimus).
1. N Engl J Med. 2007 May 31;356(22):2271-81. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J
TORISEL® (temsirolimus) |Safety Info|.
Temsirolimus DRUG NAME: Temsirolimus SYNONYM(S): CCI-7791 COMMON TRADE NAME(S): TORISEL® CLASSIFICATION: miscellaneous, cytotoxic2 Special pediatric considerations
Randomized phase III placebo-controlled.
Temsirolimus, interferon alfa, or both.
Temsirolimus (Torisel) | mTOR Inhibitor |.
Randomized phase III placebo-controlled.
temsirolimus
Temsirolimus (Torisel) | mTOR Inhibitor |.mTOR Signalweg
1. J Clin Oncol. 2013 Jan 10;31(2):195-202. doi: 10.1200/JCO.2011.38.3331. Epub 2012 Dec 10. Randomized phase III placebo-controlled trial of letrozole plus oral
temsirolimus
Te - Te index (Page 4) - Drugs.com
Browse drugs and medications alphabetically. Includes Tekturna HCT, telaprevir, Telaprevir, telavancin, Telavancin
Temsirolimus Nierenzellkarzinom Renal cell carcinoma - bevacizumab,.
The official site with content on TORISEL® (temsirolimus) for health care professionals.
Temsirolimus Nebenwirkungen
.